scholarly article | Q13442814 |
P2093 | author name string | Kazuki Nakashima | |
Yoko Yakabe | |||
P433 | issue | 7 | |
P304 | page(s) | 1650-1656 | |
P577 | publication date | 2007-07-07 | |
P1433 | published in | Bioscience, Biotechnology, and Biochemistry | Q11192374 |
P1476 | title | AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes | |
P478 | volume | 71 |
Q54389842 | AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells. |
Q89551502 | AMP-Activated Protein Kinase (AMPK) at the Crossroads Between CO2 Retention and Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease (COPD) |
Q36756228 | AMP-activated protein kinase and its downstream transcriptional pathways |
Q42704686 | AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1. |
Q35661532 | AMP-activated protein kinase regulates E3 ligases in rodent heart |
Q59134223 | AMPK Mediates Muscle Mass Change But Not the Transition of Myosin Heavy Chain Isoforms during Unloading and Reloading of Skeletal Muscles in Mice |
Q44948044 | AMPK inhibits myoblast differentiation through a PGC-1alpha-dependent mechanism. |
Q33557470 | Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1/MuRF1 signaling pathway in vitro |
Q51573173 | Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway. |
Q37801870 | Adiponectin action from head to toe. |
Q48245764 | Adiponectin inhibits inflammatory cytokines production by Beclin-1 phosphorylation and Bcl-2 mRNA destabilization: Role for autophagy induction. |
Q44866508 | Asparagine reduces the mRNA expression of muscle atrophy markers via regulating protein kinase B (Akt), AMP-activated protein kinase α, toll-like receptor 4 and nucleotide-binding oligomerisation domain protein signalling in weaning piglets after li |
Q40381038 | Aspartate inhibits LPS-induced MAFbx and MuRF1 expression in skeletal muscle in weaned pigs by regulating Akt, AMPKα and FOXO1. |
Q38189267 | Autophagic cellular responses to physical exercise in skeletal muscle. |
Q27000625 | Autophagy is essential to support skeletal muscle plasticity in response to endurance exercise |
Q48181999 | Branched-chain amino acids administration suppresses endurance exercise-related activation of ubiquitin proteasome signaling in trained human skeletal muscle. |
Q30252733 | Caloric restriction extends yeast chronological lifespan by optimizing the Snf1 (AMPK) signaling pathway |
Q36767838 | Calorie restriction: is AMPK a key sensor and effector? |
Q36956035 | Calpain activity and muscle wasting in sepsis |
Q27012762 | Cellular and molecular mechanisms of muscle atrophy |
Q42228159 | Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington's Disease |
Q36309131 | Co-ingestion of carbohydrate and whey protein increases fasted rates of muscle protein synthesis immediately after resistance exercise in rats |
Q91938273 | Deficiency of fibroblast growth factor 21 aggravates obesity-induced atrophic responses in skeletal muscle |
Q33564256 | Denervation does not Induce Muscle Atrophy Through Oxidative Stress |
Q91910488 | Dietary Aronia melanocarpa extract enhances mTORC1 signaling, but has no effect on protein synthesis and protein breakdown-related signaling, in response to resistance exercise in rat skeletal muscle |
Q41379113 | Dietary supplementation of β-guanidinopropionic acid (βGPA) reduces whole-body and skeletal muscle growth in young CD-1 mice |
Q37137271 | Does AMP-activated protein kinase negatively mediate aged fast-twitch skeletal muscle mass? |
Q59798813 | Effect of Ninjin’yoeito on the Loss of Skeletal Muscle Function in Cancer-Bearing Mice |
Q83972043 | Effects of leptin and adiponectin on proliferation and protein metabolism of porcine myoblasts |
Q89661930 | Effects of tannase-converted green tea extract on skeletal muscle development |
Q54385382 | Exercise-induced AMPK activation does not interfere with muscle hypertrophy in response to resistance training in men. |
Q36531919 | Expression of Transcription Factor FOXO3a is Decreased in Patients with Ulcerative Colitis |
Q38162721 | FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis |
Q37701112 | Foxo/atrogin induction in human and experimental myositis |
Q37855653 | Functional adiponectin resistance and exercise intolerance in heart failure. |
Q55331913 | Glucocorticoid-dependent REDD1 expression reduces muscle metabolism to enable adaptation under energetic stress. |
Q35580888 | High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1). |
Q37690120 | IGF-1 potentiates sensory innervation signalling by modulating the mitochondrial fission/fusion balance |
Q38759079 | Independent AMP and NAD signaling regulates C2C12 differentiation and metabolic adaptation |
Q93098906 | Influence of shortened recovery between resistance exercise sessions on muscle-hypertrophic effect in rat skeletal muscle |
Q36185141 | Insulin down-regulates the expression of ubiquitin E3 ligases partially by inhibiting the activity and expression of AMP-activated protein kinase in L6 myotubes |
Q33840333 | Insulin effects on glucose tolerance, hypermetabolic response, and circadian-metabolic protein expression in a rat burn and disuse model |
Q26765148 | Insulin resistance and sarcopenia: mechanistic links between common co-morbidities |
Q38064396 | Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. |
Q38204299 | Interference between concurrent resistance and endurance exercise: molecular bases and the role of individual training variables |
Q34597522 | Intracellular signaling pathways regulating net protein balance following diaphragm muscle denervation. |
Q52926464 | Involvement of AMPK in regulating slow-twitch muscle atrophy during hindlimb unloading in mice. |
Q55062189 | L-Alanylglutamine inhibits signaling proteins that activate protein degradation, but does not affect proteins that activate protein synthesis after an acute resistance exercise. |
Q27342830 | Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice |
Q36422693 | Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes |
Q42944434 | Lysine suppresses myofibrillar protein degradation by regulating the autophagic-lysosomal system through phosphorylation of Akt in C2C12 cells |
Q34572209 | MST1, a key player, in enhancing fast skeletal muscle atrophy |
Q38165141 | Mechanical properties of respiratory muscles |
Q64274537 | Mechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures |
Q36103986 | Mechanisms of Cachexia in Chronic Disease States |
Q28541996 | Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study |
Q34265028 | Minireview: hey U(PS): metabolic and proteolytic homeostasis linked via AMPK and the ubiquitin proteasome system |
Q39713513 | Mitochondrial fission and remodelling contributes to muscle atrophy. |
Q48066927 | Molecular characterization and association analysis of FBXO40 with partial hematological indexes in pig. |
Q37138465 | Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia |
Q34085586 | Muscle protein breakdown has a minor role in the protein anabolic response to essential amino acid and carbohydrate intake following resistance exercise. |
Q38303979 | Muscle wasting in disease: molecular mechanisms and promising therapies |
Q92898593 | Network Pharmacology-Based Investigation into the Mechanisms of Quyushengxin Formula for the Treatment of Ulcerative Colitis |
Q34652034 | PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting |
Q24634396 | Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy |
Q47811763 | Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls |
Q37893657 | Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks |
Q85053744 | Quercetin Prevents Unloading-Derived Disused Muscle Atrophy by Attenuating the Induction of Ubiquitin Ligases in Tail-Suspension Mice |
Q37912719 | Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass |
Q34756301 | Regulation of AMPK by the ubiquitin proteasome system |
Q37484275 | Regulation of skeletal muscle oxidative capacity and muscle mass by SIRT3. |
Q86999646 | Respiratory muscle plasticity |
Q64259074 | Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway |
Q37000179 | Sepsis and AMPK Activation by AICAR Differentially Regulate FoxO-1, -3 and -4 mRNA in Striated Muscle |
Q39032975 | THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES. |
Q55653938 | The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting. |
Q57476059 | The Role of AMPK in the Regulation of Skeletal Muscle Size, Hypertrophy, and Regeneration |
Q51396253 | The effect of four different feeding regimens from rearing period to sexual maturity on breast muscle protein turnover in broiler breeder parent stock. |
Q47314372 | The effects of dietary β-guanidinopropionic acid on growth and muscle fiber development in juvenile red porgy, Pagrus pagrus |
Q34031423 | The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse |
Search more.